Balentine LLC’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-102
| Closed | -$11K | – | 928 |
|
|
2020
Q2 | $11K | Buy |
102
+29
| +40% | +$3.13K | ﹤0.01% | 546 |
|
|
2020
Q1 | $7K | Sell |
73
-285
| -80% | -$27.3K | ﹤0.01% | 441 |
|
|
2019
Q4 | $39K | Buy |
358
+327
| +1,055% | +$35.6K | ﹤0.01% | 226 |
|
|
2019
Q3 | $3K | Buy |
31
+24
| +343% | +$2.32K | ﹤0.01% | 626 |
|
|
2019
Q2 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 752 |
|
|
2018
Q3 | – | Sell |
-70
| Closed | -$9K | – | 394 |
|
|
2018
Q2 | $9K | Buy |
+70
| New | +$9K | ﹤0.01% | 104 |
|
|
2018
Q1 | – | Sell |
-170
| Closed | -$20K | – | 572 |
|
|
2017
Q4 | $20K | Sell |
170
-3
| -2% | -$353 | ﹤0.01% | 383 |
|
|
2017
Q3 | $24K | Sell |
173
-48
| -22% | -$6.66K | ﹤0.01% | 370 |
|
|
2017
Q2 | $27K | Buy |
221
+90
| +69% | +$11K | ﹤0.01% | 332 |
|
|
2017
Q1 | $16K | Hold |
131
| – | – | ﹤0.01% | 379 |
|
|
2016
Q4 | $16K | Sell |
131
-36
| -22% | -$4.4K | ﹤0.01% | 356 |
|
|
2016
Q3 | $20K | Buy |
167
+36
| +27% | +$4.31K | ﹤0.01% | 280 |
|
|
2016
Q2 | $15K | Buy |
+131
| New | +$15K | ﹤0.01% | 285 |
|